Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
ID06954701

Evaluation of a Novel Personalizable Pessary for the Treatment of Pelvic Organ Prolapse

Led by University of Alberta · Updated on 2026-06-04

43

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University of Alberta

Lead Sponsor

A

Alberta Innovates Health Solutions

Collaborating Sponsor

AI-Summary

What this Trial Is About

Pelvic organ prolapse (POP) affects about half of Canadian women during their lifetime, causing symptoms like urine leakage, discomfort, and embarrassment. This condition involves organs such as the bladder, uterus, and bowel pushing into the vagina. Researchers are evaluating a new personalizable pessary designed with a natural vaginal shape, which is easier to use and custom fit, compared to traditional pessaries. The study aims to assess the safety and effectiveness of this novel device for managing POP symptoms and improving quality of life. Participants who have previously used a standard pessary will first continue with their usual pessary for one month. Then, they will use the new personalizable pessary for three months. This device is made from biocompatible silicone and is produced using 3D printing technology to allow a better fit and easier self-care. The study will compare symptom changes, comfort, ease of use, and any side effects between the traditional and new pessaries. During the study, participants will complete questionnaires about their POP symptoms, sexual function, and quality of life. Researchers will also measure physical assessments and collect feedback on the pessaries’ comfort and self-management. The main outcome is the change in the Pelvic Floor Distress Inventory-20 score after using the new pessary. The total participation time is about four months, including one month with the standard device and three months with the new pessary. Safety and adherence will be closely monitored throughout the study.

CONDITIONS

Brief Title

Evaluation of a Personalizable Pessary for Pelvic Organ Prolapse

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients assigned female at birth
  • At least 18 years old at time of screening
  • Patients with symptomatic pelvic organ prolapse using a pessary for 3 months or more
  • Capable of giving informed consent
  • Fluency in English
Not Eligible

You will not qualify if you...

  • Pregnancy
  • Short vaginal length (less than 5 cm) or subjective vaginal narrowing
  • Vaginal erosion due to current pessary
  • Presence of vesicovaginal fistula
  • Presence of rectovaginal fistula
  • Current treatment for vaginal, rectal, or bladder tumor
  • Presence of open wound or tear near vagina or anus prior to removal of current pessary
  • Presence of pelvic, vaginal, or urinary infection requiring treatment
  • Ongoing treatment of recurrent urinary tract or vaginal infections
  • Inflammatory bowel disease
  • Chronic pain syndromes of pelvic or anorectal origin
  • Previous pelvic floor surgery in last 12 months
  • Congenital malformation of bladder, rectum, or vagina
  • Significant medical condition interfering with study participation (psychologic, neurologic, active drug/alcohol abuse, ambulatory restrictions, etc.)
  • Planning pregnancy in next 6 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Standard Pessary Use

Duration - 1 month

Participants use their standard pessary device as a control for comparison.

1 visit at start and 1 visit at end of this period

Treatment with Novel Personalizable Pessary

Duration - 3 months

Participants are fit with and use the novel personalizable pessary to assess its safety, efficacy, and ease of use.

Monthly visits during the treatment period

Trial Site Locations

Total: 1 location

1

Dale Sheard Centre for Solutions in Women's Health

Edmonton, Alberta, Canada, T5H3V9

Actively Recruiting

Loading map...

Research Team

M

May Sanaee, BSc MD FRCSC MHScEd

L

Laura Reyes Martinez, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

Accelerometer Measured Early Recovery After Prolapse Surgery...

Pelvic Organ Prolapse

Actively Recruiting

7 locations

Energy-based Opportunistic Salpingo-oophorectomy During Vagi...

Pelvic Organ Prolapse (POP)

Actively Recruiting

1 location

Development and Validation of a Risk Prediction Model for De...

Pelvic Organ Prolapse (POP)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here